DGDimitra Giota

Dimitra Giota

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dimitra Giota has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association Between Vitamin B12, Folate, and Erythrocyte Indices in Cats: A Retrospective Study

    by Argyrios Ginoudis, Dimitra Giota, Dimitrios Galiatsatos, Zoe Polizopoulou, Alexandros Konstantinidis, Dimitra Pardali

    Background/Objectives: Vitamin B12 (cobalamin) and folate deficiencies are classically associated with impaired DNA synthesis and megaloblastic erythropoiesis, but their hematologic expression in cats remains incompletely characterized. This exploratory retrospective study evaluated associations between serum cobalamin and folate concentrations and routine erythrocyte indices in 88 cats. Methods: Retrospective laboratory data from 88 cats were evaluated. Serum cobalamin and folate measurements were available for subsets of the study population, and each analysis was restricted to observations with the required measurements. Pearson and Spearman correlations were calculated between vitamin concentrations and red blood cell count (RBC), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), and reticulocyte count. Erythrocyte variables were also compared between cats classified as having low versus non-low vitamin concentrations using Mann–Whitney tests. The primary analyses used unadjusted two-sided p values and were interpreted as exploratory. Results: The final study population comprised 88 client-owned cats, with serum cobalamin and folate measurements available for 83 and 68 cats, respectively. No statistically significant correlations were identified between serum cobalamin or folate concentrations and the evaluated erythrocyte indices (all p > 0.05). Following the exclusion of observations without the relevant serum vitamin measurement, no statistically significant differences were observed between low- and non-low-vitamin groups. MCV was numerically lower in cats with low folate concentrations (median 47.0 vs. 48.1 fL), although the difference was small (1.1 fL) and not statistically significant (p = 0.071). These exploratory findings should be interpreted cautiously because of multiple comparisons and limited subgroup sizes. Conclusions: In this retrospective feline population, routine erythrocyte indices showed weak and statistically non-significant associations with serum cobalamin and folate concentrations. These findings suggest that normal erythrocyte indices alone should not be used to exclude low serum vitamin concentrations. Prospective studies incorporating functional biomarkers and diagnostic performance analyses are needed before definitive conclusions can be drawn regarding the clinical utility of CBC indices for identifying vitamin abnormalities.

  • Open Access

    Assessment of Oxidative Stress-Related Markers and Inflammatory Proteins in Serum and CSF Samples of Dogs with Different Types of Epilepsy

    by Rania D. Baka, Argyrios Ginoudis, Maria Botia, Juan Diego Garcia-Martinez, Ioannis Savvas, Dimitra Giota, Zoe Polizopoulou

    Background: Oxidative stress contributes to the development and progression of epilepsy and is connected with neuroinflammation during epileptic seizures. Cholinesterase has a modulatory role, and oxytocin has antiepileptic properties. The purpose of this study was to assess selective inflammatory (C-Reactive Protein, CRP) and oxidative stress markers [Paraoxonase-1 (PON1), cupric reducing antioxidant capacity (CUPRAC), ferric reducing antioxidant power (FRAP), cholinesterase, and oxytocin in serum and cerebrospinal fluid (CSF) samples of dogs with different types of epilepsy. Methods: There were four groups of dogs; A: healthy controls; B: idiopathic epilepsy receiving antiepileptic medication; C: idiopathic epilepsy without antiepileptic medication; and D: structural epilepsy. CRP, PON1, CUPRAC, and cholinesterase were evaluated in serum and PON1, CUPRAC, FRAP, cholinesterase and oxytocin were evaluated in CSF samples. Group differences were evaluated using the ANOVA test, followed by post hoc analyses or Kruskal–Wallis/Dunn’s test. Results: Fifty-one serum and 26 CSF samples were analyzed. CSF PON1 was significantly different in group D compared with groups A and C (p = 0.044 and p = 0.008, respectively). CSF cholinesterase was significantly different in group D compared with groups A, B and C (p = 0.003, p = 0.025, and p = 0.033, respectively). Conclusions: Structural epilepsy may influence PON1 and cholinesterase levels in CSF samples. Compared with CSF, serum was not the most suitable biological material to investigate oxidative stress and inflammatory markers.


  • Open Access

    Assessment of Oxidative Stress-Related Markers and Inflammatory Proteins in Serum and CSF Samples of Dogs with Different Types of Epilepsy

    by Rania D. Baka, Argyrios Ginoudis, María Botía, Juan Diego Garcia-Martinez, Ioannis Savvas, Dimitra Giota, Zoe Polizopoulou

    Background: Oxidative stress contributes to the development and progression of epilepsy and is connected with neuroinflammation during epileptic seizures. Cholinesterase has a modulatory role, and oxytocin has antiepileptic properties. The purpose of this study was to assess selective inflammatory (CRP) and oxidative stress markers (PON1, CUPRAC, FRAP), cholinesterase, and oxytocin in serum and CSF samples of dogs with different types of epilepsy. Methods: There were four groups of dogs; A: healthy controls; B: idiopathic epilepsy receiving antiepileptic medication; C: idiopathic epilepsy without antiepileptic medication; and D: structural epilepsy. CRP, PON1, CUPRAC, and cholinesterase were evaluated in serum and PON1, CUPRAC, FRAP, cholinesterase and oxytocin were evaluated in CSF samples. Group differences were evaluated using ANOVA or Kruskal–Wallis tests, followed by post-hoc analyses. Results: Fifty-one serum and 26 CSF samples were analyzed. CSF PON1 was significantly different in group D compared to groups A and C (p=0.044 and p=0.008, respectively). CSF cholinesterase was significantly different in group D compared to groups A, B and C (p=0.003, p=0.025, p=0.033, respectively). Conclusions: Structural epilepsy may influence PON1, CUPRAC and cholinesterase levels in CSF samples. Compared to CSF, serum was not the most suitable biological material to investigate oxidative stress and inflammatory markers.